It's A Monthly Thing Limited – Trademark Portfolio

Entity Type: 99

It's A Monthly Thing Limited holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 4 Nice Classification classes.

Unit 2, Oyster Park, 109 Chertsey Road

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

It's A Monthly Thing Limited's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

41
Education & Entertainment (2 filings)

Education; providing of training; entertainment; sporting and cultural activities

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does It's A Monthly Thing Limited have?

It's A Monthly Thing Limited has 3 U.S. trademarks filed with the USPTO.

What trademark classes does It's A Monthly Thing Limited file in?

It's A Monthly Thing Limited files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.

What is It's A Monthly Thing Limited's trademark registration success rate?

It's A Monthly Thing Limited has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.